• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mild cognitive impairment: animal models.轻度认知障碍:动物模型
Dialogues Clin Neurosci. 2004 Dec;6(4):369-77. doi: 10.31887/DCNS.2004.6.4/gpepeu.
2
Mild Cognitive Impairment Is Characterized by Deficient Brainstem and Cortical Representations of Speech.轻度认知障碍的特征是脑干和皮质对言语的表征不足。
J Neurosci. 2017 Mar 29;37(13):3610-3620. doi: 10.1523/JNEUROSCI.3700-16.2017. Epub 2017 Mar 7.
3
Streptozotocin Induces Mild Cognitive Impairment at Appropriate Doses in Mice as Determined by Long-Term Potentiation and the Morris Water Maze.链脲佐菌素在适当剂量下可诱导小鼠出现轻度认知障碍,这是通过长时程增强和莫里斯水迷宫实验确定的。
J Alzheimers Dis. 2016 Jul 27;54(1):89-98. doi: 10.3233/JAD-150979.
4
Successful vs. Unsuccessful Aging in the Rhesus Monkey恒河猴的成功衰老与非成功衰老
5
Amelioration of early cognitive deficits by aged garlic extract in Alzheimer's transgenic mice.老年大蒜提取物改善阿尔茨海默病转基因小鼠的早期认知缺陷。
Phytother Res. 2007 Jul;21(7):629-40. doi: 10.1002/ptr.2122.
6
Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.突触补偿作为阿尔茨海默病长期轻度认知障碍的可能原因:来自该疾病转基因小鼠模型的启示
J Alzheimers Dis. 2017;56(4):1385-1401. doi: 10.3233/JAD-160845.
7
Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.加速衰老对阿尔茨海默病 APP/PS1 小鼠模型学习记忆、运动和焦虑样行为的影响。
J Neurol Sci. 2013 Dec 15;335(1-2):145-54. doi: 10.1016/j.jns.2013.09.018. Epub 2013 Sep 21.
8
Is Mild Cognitive Impairment a Precursor of Alzheimer's Disease? Short Review.轻度认知障碍是阿尔茨海默病的先兆吗?简短综述。
Cent Eur J Public Health. 2015 Dec;23(4):365-7. doi: 10.21101/cejph.a4414.
9
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.对于临床试验而言,轻度认知障碍可与阿尔茨海默病及正常衰老相区分。
Arch Neurol. 2004 Jan;61(1):59-66. doi: 10.1001/archneur.61.1.59.
10
Redox Proteomics of Oxidatively Modified Brain Proteins in Mild Cognitive Impairment轻度认知障碍中氧化修饰脑蛋白的氧化还原蛋白质组学

引用本文的文献

1
Cognitive training of mice attenuates age-related decline in associative learning and behavioral flexibility.对小鼠进行认知训练可减轻与年龄相关的联想学习和行为灵活性下降。
Front Behav Neurosci. 2024 Mar 14;18:1326501. doi: 10.3389/fnbeh.2024.1326501. eCollection 2024.
2
Vortioxetine Reverses Impairment of Visuospatial Memory and Cognitive Flexibility Induced by Degarelix as a Model of Androgen Deprivation Therapy in Rats.伏硫西汀可逆转去势瑞林诱导的大鼠空间视觉记忆和认知灵活性损伤,去势瑞林作为大鼠雄激素剥夺疗法的模型。
Neuroendocrinology. 2024;114(3):279-290. doi: 10.1159/000535365. Epub 2023 Dec 16.
3
Assessing cognitive decline in the aging brain: lessons from rodent and human studies.评估衰老大脑中的认知衰退:来自啮齿动物和人类研究的经验教训。
NPJ Aging. 2023 Oct 19;9(1):23. doi: 10.1038/s41514-023-00120-6.
4
Combination of dasatinib and quercetin improves cognitive abilities in aged male Wistar rats, alleviates inflammation and changes hippocampal synaptic plasticity and histone H3 methylation profile.达沙替尼与槲皮素联合使用可改善老年雄性 Wistar 大鼠的认知能力,减轻炎症,并改变海马突触可塑性和组蛋白 H3 甲基化谱。
Aging (Albany NY). 2022 Jan 18;14(2):572-595. doi: 10.18632/aging.203835.
5
Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders.重新审视 sigma-1 受体作为治疗情感和认知障碍的生物靶点。
Neurosci Biobehav Rev. 2022 Jan;132:1114-1136. doi: 10.1016/j.neubiorev.2021.10.037. Epub 2021 Nov 1.
6
Detection and Prediction of Mild Cognitive Impairment in Alzheimer's Disease Mice.阿尔茨海默病小鼠轻度认知障碍的检测与预测。
J Alzheimers Dis. 2020;77(3):1209-1221. doi: 10.3233/JAD-200675.
7
A New Rat Model of Chronic Cerebral Hypoperfusion Resulting in Early-Stage Vascular Cognitive Impairment.一种导致早期血管性认知障碍的慢性脑灌注不足新大鼠模型。
Front Aging Neurosci. 2020 Apr 15;12:86. doi: 10.3389/fnagi.2020.00086. eCollection 2020.
8
Evaluating the Memory Enhancing Effects of in Mouse Models of Mild Cognitive Impairments.评价 在轻度认知障碍小鼠模型中的增强记忆作用。
Nutrients. 2019 Dec 30;12(1):97. doi: 10.3390/nu12010097.
9
Alzheimer's Disease Pharmacotherapy in Relation to Cholinergic System Involvement.阿尔茨海默病药物治疗与胆碱能系统参与的关系。
Biomolecules. 2019 Dec 26;10(1):40. doi: 10.3390/biom10010040.
10
ABCC9-related Intellectual disability Myopathy Syndrome is a K channelopathy with loss-of-function mutations in ABCC9.ABCC9 相关智力残疾肌病综合征是一种 K 通道病,其 ABCC9 存在功能丧失突变。
Nat Commun. 2019 Oct 1;10(1):4457. doi: 10.1038/s41467-019-12428-7.

本文引用的文献

1
Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment.认知衰老、轻度认知障碍、阿尔茨海默病和血管性认知障碍的神经心理学
Eur J Pharmacol. 2004 Apr 19;490(1-3):83-6. doi: 10.1016/j.ejphar.2004.02.046.
2
Decreased level of brain acetylcholine and memory disturbance in APPsw mice.APPsw小鼠脑内乙酰胆碱水平降低与记忆障碍
Neurobiol Aging. 2004 Apr;25(4):483-90. doi: 10.1016/S0197-4580(03)00122-2.
3
Enhancement of working memory in aged monkeys by a sensitizing regimen of dopamine D1 receptor stimulation.通过多巴胺D1受体刺激的致敏方案增强老年猴子的工作记忆。
J Neurosci. 2004 Feb 11;24(6):1446-50. doi: 10.1523/JNEUROSCI.3987-03.2004.
4
Effects of acute acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: Functional imaging of the conscious monkey brain using animal PET in combination with microdialysis.
Synapse. 2004 Apr;52(1):1-10. doi: 10.1002/syn.10310.
5
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.对于临床试验而言,轻度认知障碍可与阿尔茨海默病及正常衰老相区分。
Arch Neurol. 2004 Jan;61(1):59-66. doi: 10.1001/archneur.61.1.59.
6
The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys.AMPA受体正向调节剂IDRA 21对幼年和老年恒河猴延迟匹配表现的影响。
Neuropharmacology. 2004 Jan;46(1):10-22. doi: 10.1016/j.neuropharm.2003.07.002.
7
Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment.通过长期银杏叶治疗预防阿尔茨海默病转基因小鼠模型中与年龄相关的空间记忆缺陷。
Exp Neurol. 2003 Nov;184(1):510-20. doi: 10.1016/s0014-4886(03)00399-6.
8
Age-related decline in spatial learning and memory: attenuation by captopril.
Clin Exp Hypertens. 2003 Oct;25(7):455-74. doi: 10.1081/ceh-120024988.
9
Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population.老年人群中非痴呆性认知障碍的患病率及其与血管危险因素的关联。
J Neurol. 2003 Aug;250(8):907-12. doi: 10.1007/s00415-003-1094-0.
10
Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment.轻度认知障碍:患病率、预后、病因及治疗
Lancet Neurol. 2003 Jan;2(1):15-21. doi: 10.1016/s1474-4422(03)00262-x.

轻度认知障碍:动物模型

Mild cognitive impairment: animal models.

作者信息

Pepeu Giancarlo

机构信息

Department of Pharmacology, University of Florence, Florence, Italy.

出版信息

Dialogues Clin Neurosci. 2004 Dec;6(4):369-77. doi: 10.31887/DCNS.2004.6.4/gpepeu.

DOI:10.31887/DCNS.2004.6.4/gpepeu
PMID:22034045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3181813/
Abstract

Mild cognitive impairment (MCI) is an aspect of cognitive aging that is considered to be a transitional state between normal aging and the dementia into which it may convert. Appropriate animal models are necessary in order to understand the pathogenic mechanisms of MCI and develop drugs for its treatment. In this review, we identify the features that should characterize an animal model of MCI, namely old age, subtle memory impairment, mild neuropathological changes, and changes in the cholinergic system, and the age at which these features can be detected in laboratory animals. These features should occur in aging animals with normal motor activity and feeding behavior. The animal models may be middle-aged rats and mice, rats with brain ischemia, transgenic mice overexpressing amyloid precursor protein and presenilin 1 (tested at an early stage), or aging monkeys. Memory deficits can be detected by selecting appropriately difficult behavioral tasks, and the deficits can be associated with neuropathological alterations. The reviewed literature demonstrates that, under certain conditions, these animal species can be considered to be MCI models, and that cognitive impairment in these models responds to drug treatment.

摘要

轻度认知障碍(MCI)是认知衰老的一个方面,被认为是正常衰老与可能转化为的痴呆之间的过渡状态。为了理解MCI的致病机制并开发治疗药物,合适的动物模型是必要的。在本综述中,我们确定了MCI动物模型应具备的特征,即老年、轻微记忆障碍、轻度神经病理变化以及胆碱能系统变化,以及在实验动物中可检测到这些特征的年龄。这些特征应出现在运动活动和进食行为正常的衰老动物中。动物模型可以是中年大鼠和小鼠、脑缺血大鼠、过表达淀粉样前体蛋白和早老素1的转基因小鼠(在早期进行测试)或衰老猴子。通过选择难度适当的行为任务可以检测到记忆缺陷,并且这些缺陷可能与神经病理改变有关。综述文献表明,在某些条件下,这些动物物种可被视为MCI模型,并且这些模型中的认知障碍对药物治疗有反应。